Prostatis Group’s iShares Core S&P Small-Cap ETF IJR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,367
Closed -$1.77M 145
2023
Q4
$1.77M Buy
16,367
+12,943
+378% +$1.25M 0.74% 38
2023
Q3
$323K Sell
3,424
-203,910
-98% -$20.4M 0.16% 80
2023
Q2
$1.14M Buy
207,334
+194,503
+1,516% +$18.5M 0.53% 46
2023
Q1
$1.2M Buy
12,831
+10,253
+398% +$1.03M 0.63% 42
2022
Q4
$244K Buy
+2,578
New +$247K 0.15% 87
2022
Q3
Sell
-3,370
Closed -$311K 67
2022
Q2
$311K Sell
3,370
-224
-6% -$22.3K 0.49% 22
2022
Q1
$388K Sell
3,594
-710
-16% -$76.6K 0.31% 46
2021
Q4
$493K Sell
4,304
-597
-12% -$68K 0.3% 52
2021
Q3
$535K Buy
4,901
+666
+16% +$73.3K 0.32% 55
2021
Q2
$478K Sell
4,235
-1,319
-24% -$147K 0.33% 57
2021
Q1
$603K Sell
5,554
-2,690
-33% -$282K 0.47% 53
2020
Q4
$758K Sell
8,244
-8,943
-52% -$735K 0.63% 38
2020
Q3
$1.21M Buy
17,187
+1,236
+8% +$88.6K 1.14% 23
2020
Q2
$1.09M Sell
15,951
-20,981
-57% -$1.32M 2.19% 14
2020
Q1
$2.07M Buy
36,932
+5,588
+18% +$416K 2.95% 11
2019
Q4
$2.63M Buy
+31,344
New +$2.52M 2.38% 15

Other funds holding IJR

Prostatis Group's IJR Position: Q1 2024 in Review

Prostatis Group sold out of iShares Core S&P Small-Cap ETF (IJR) in Q1 2024, closing a stake of 16,367 shares — an estimated $1.77M sold.

Prostatis Group first reported a position in IJR in Q4 2019 and held it in 16 quarters. The position peaked at $2.63M in Q4 2019. 2,325 funds tracked by Wall St. Rank hold IJR as of Q1 2024.

  • Prostatis Group reported no remaining iShares Core S&P Small-Cap ETF position as of Q1 2024 after selling out during the quarter.
  • Prostatis Group sold 16,367 iShares Core S&P Small-Cap ETF shares in Q1 2024, an estimated $1.77M.
  • Prostatis Group first reported a position in iShares Core S&P Small-Cap ETF in Q4 2019 and held it in 16 quarters.
  • Prostatis Group's iShares Core S&P Small-Cap ETF position peaked at $2.63M in Q4 2019.
  • 2,325 funds tracked by Wall St. Rank held iShares Core S&P Small-Cap ETF as of Q1 2024.

Based on Prostatis Group's 13F filing for Q1 2024, filed 21 Mar 2025.